Research article · 23 Dec 2015
Conference abstract
How does massively parallel sequencing contribute to biomarker development?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The development of validated and qualified preclinical and clinical biomarkers as surrogate endpoints of toxicity or disease or as early diagnostic indicators of disease progression is a complex process. The development of microarrays in the 1990?s had initially raised hopes for faster and possibly more reproducible generation of data which could be used for biomarker discovery, arguably with more or less success. Genomics and related -omics data from massively parallel sequencing (MPS) technologies have to be tested against even higher expectations and are being put under scrutiny. Comparative analyses of microarray data and MPS data will be reviewed, implications and challenges for biomarker development will be discussed.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 2013
Exploitation of Massively Parallel Architectures for Drug Discovery
Brief report · 30 Dec 2024
Revolutionizing Forensic Science: Massively Parallel Sequencing for Transcriptomic Profiling in Forensic Applications
Conference abstract · 19 Sep 2024
Discrimination of monozygotic twins using mtDNA heteroplasmy through probe capture enrichment and massively parallel sequencing
Short communication · 31 Jan 2024
Advancements in Understanding Inherited Cardiomyopathies through Massive Parallel DNA Sequencing
More from this journal
The newest in Journal of Pharmacogenomics & Pharmacoproteomics.
Article · 31 Dec 2025
Molecular Phenotyping: Integrated Biological Profiles for Understanding Cellular Function and Disease
Article · 31 Dec 2025
Genetic Determinants of Individual Drug Response
Article · 31 Dec 2025
Genetic Variation in Drug Metabolism, Transport, and Treatment Response
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacogenomics & Pharmacoproteomics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Andreas Scherer”

